questionText: To ask the Secretary of State for Health and Social Care, with reference to the National Patient Safety Alert entitled Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets, issued on 27 September 2023, what steps his Department is taking to (a) support and (b) provide information to people who are impacted by supply disruptions for their prescribed medication.
answerText: We are aware of supply issues affecting medicines used for the management of attention deficit hyperactivity disorder (ADHD). We have issued communications, in the form of a National Patient Safety Alert, to the National Health Service to advise healthcar...
heading: Drugs: Shortages